The drug is just one of two on the market currently approved specifically to treat the diabetes-related eye condition, among other eye ailments.

Researchers recently published promising results from a mouse study on the use of an asthma drug to inhibit the early stages of retinopathy.

The new treatment received approval after positive results were released earlier this year from the PANORAMA trial.